title: An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA.
abstract: The binding of the antitumor drug CC-1065 has been studied with nuclear magnetic resonance (NMR) spectroscopy. This study involves two parts, the elucidation of the covalent binding site of the drug to DNA and a detailed investigation of the noncovalent interactions of CC-1065 with a DNA fragment through analysis of 2D NOE (NOESY) experiments. A CC-1065-DNA adduct was prepared, and an adenine adduct was released upon heating. NMR (1H and 13C) analysis of the adduct shows that the drug binds to N3 of adenine by reaction of its cyclopropyl group. The reaction pathway and product formed were determined by analysis of the 13C DEPT spectra. An octamer duplex, d(CGATTAGC.GCTAATCG), was synthesized and used in the interaction study of CC-1065 and the oligomer. The duplex and the drug-octamer complex were both analyzed by 2D spectroscopy (COSY, NOESY). The relative intensity of the NOEs observed between the drug (CC-1065) and the octamer duplex shows conclusively that the drug is located in the minor groove, covalently attached to N3 of adenine 6 and positioned from the 3'----5' end in relation to strand A [d(CGATTA6GC)]. A mechanism for drug binding and stabilization can be inferred from the NOE data and model-building studies.
authors.affiliation: Pharmaceutical Research and Development Division, Upjohn Company, Kalamazoo, Michigan 49001.
authors.forename: T A
authors.initials: TA
authors.lastname: Scahill
authors.forename: R M
authors.initials: RM
authors.lastname: Jensen
authors.forename: D H
authors.initials: DH
authors.lastname: Swenson
authors.forename: N T
authors.initials: NT
authors.lastname: Hatzenbuhler
authors.forename: G
authors.initials: G
authors.lastname: Petzold
authors.forename: W
authors.initials: W
authors.lastname: Wierenga
authors.forename: N D
authors.initials: ND
authors.lastname: Brahme
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives*; D000903:Antibiotics, Antineoplastic / Q000378:metabolism*; D001483:Base Sequence; D055598:Chemical Phenomena; D002621:Chemistry; D004247:DNA / Q000378:metabolism*; D018736:DNA Adducts; D000080890:Duocarmycins; D007211:Indoles; D007933:Leucomycins / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation
chemical_list: D000903:Antibiotics, Antineoplastic; C055641:CC-1065-(N(3)-adenine)-DNA; D018736:DNA Adducts; D000080890:Duocarmycins; D007211:Indoles; D007933:Leucomycins; C018782:CC 1065; D004247:DNA; D000225:Adenine